John H Bushweller

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Venues

Science advances

Nature reviews. Cancer

Nature structural & molecular biology

Nature communications

University of Virginia

University of California Berkeley (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Virginia Jul 01 1998

United States

Professor :: Molecular Physiology and Biophysics

Dartmouth College Jul 01 1993 - Jun 30 1998

United States

Assistant Professor :: Chemistry

Education History

University of California Berkeley Jul 01 1984 - Jan 01 1990

United States

PHD :: Chemistry

Publications

Philomina Sona Peramangalam, Sridevi Surapally, Anthony J Veltri, Shikan Zheng, Robert Burns, Nan Zhu, Sridhar Rao, Carsten Muller-Tidow, John H Bushweller, John Anto Pulikkan
N-MYC regulates cell survival via eIF4G1 in inv(16) acute myeloid leukemia. Science advances 10 (9) (2024)
Philomina Sona Peramangalam, Sridevi Surapally, Anthony J Veltri, Shikan Zheng, Robert Burns, Nan Zhu, Sridhar Rao, Carsten Muller-Tidow, John H Bushweller, John Anto Pulikkan
N-MYC regulates cell survival via eIF4G1 in inv(16) acute myeloid leukemia. Science advances 10 (9) (2024)
Charles R Schmidt, Nicholas J Achille, Aravinda Kuntimaddi, Adam M Boulton, Benjamin I Leach, Shubin Zhang, Nancy J Zeleznik-Le, John H Bushweller
BCOR Binding to MLL-AF9 Is Essential for Leukemia via Altered EYA1, SIX, and MYC Activity. Blood cancer discovery 1 (2) (2022)
Hanuman P Kalmode, Izabella Podsiadly, Ashish Kabra, Adam Boulton, Prabhakar Reddy, Yan Gao, Christopher Li, John H Bushweller
Small-Molecule Inhibitors of the MLL1 CXXC Domain, an Epigenetic Reader of DNA Methylation. ACS medicinal chemistry letters 13 (8) (2022)
Kee-Beom Kim, Ashish Kabra, Dong-Wook Kim, Yongming Xue, Yuanjian Huang, Pei-Chi Hou, Yunpeng Zhou, Leilani J Miranda, Jae-Il Park, Xiaobing Shi, Timothy P Bender, John H Bushweller, Kwon-Sik Park
KIX domain determines a selective tumor-promoting role for EP300 and its vulnerability in small cell lung cancer. Science advances 8 (7) (2022)
Jason P Wray, Elitza M Deltcheva, Charlotta Boiers, Simon E Richardson, Jyoti Bikram Chhetri, John Brown, Sladjana Gagrica, Yanping Guo, Anuradha Illendula, Joost H A Martens, Hendrik G Stunnenberg, John H Bushweller, Rachael Nimmo, Tariq Enver
Regulome analysis in B-acute lymphoblastic leukemia exposes Core Binding Factor addiction as a therapeutic vulnerability. Nature communications 13 (1) (2022)
Lei Yu, Greggory Myers, Chia-Jui Ku, Emily Schneider, Yu Wang, Sharon A Singh, Natee Jearawiriyapaisarn, Andrew D White, Takashi Moriguchi, Rami Khoriaty, Masayuki Yamamoto, Michael G Rosenfeld, Julien Pedron, John H Bushweller, Kim-Chew Lim, James Douglas Engel
An erythroid-to-myeloid cell fate conversion is elicited by LSD1 inactivation. Blood 138 (18) (2021)
John H Bushweller
Targeting transcription factors in cancer - from undruggable to reality. Nature reviews. Cancer 19 (11) (2019)
Yunpeng Zhou, John H Bushweller
Solution structure and elevator mechanism of the membrane electron transporter CcdA. Nature structural & molecular biology 25 (2) (2018)

John H Bushweller.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

John H Bushweller